Cure My Disease

Don't miss your cure!

 Log in / Sign up

Strength training and protein diet may reverse frailty in sarcopenic elderly women

NCT ID NCT07627919

Recruiting now Disease control Sponsor: Cairo University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study investigates whether combining supervised resistance exercise three times a week with a high-protein diet can reduce frailty and improve balance in obese women aged 60–70 who have sarcopenia (age-related muscle loss). Sixty participants are randomly assigned to either the combined program or a control group receiving only dietary advice. The goal is to see if this lifestyle approach can help restore strength and mobility.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
supervised resistance exercise training and a high-protein diet
What this could lead to
If successful, this combination could offer a simple, non-drug way to reduce frailty and improve quality of life in older women with sarcopenic obesity.
What could go wrong
This is a small, early-stage study with 60 participants, so results may not apply to everyone. The control group also receives a high-protein diet, making it harder to isolate the exercise effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESE SARCOPENIC OBESITY

Contacts and locations

Locations

  • Fawkia hospital outpatient clinic

    RECRUITING

    El-Sheikh Zayed City, Egypt

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.